Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors.
Huang, H., Hutta, D.A., Hu, H., DesJarlais, R.L., Schubert, C., Petrounia, I.P., Chaikin, M.A., Manthey, C.L., Player, M.R.(2008) Bioorg Med Chem Lett 18: 2355-2361
- PubMed: 18342505 
- DOI: https://doi.org/10.1016/j.bmcl.2008.02.070
- Primary Citation of Related Structures:  
3BEA - PubMed Abstract: 
A series of pyrimidinopyridones has been designed, synthesized and shown to be potent and selective inhibitors of the FMS tyrosine kinase. Introduction of an amide substituent at the 6-position of the pyridone core resulted in a significant potency increase. Compound 24 effectively inhibited in vivo LPS-induced TNF in mice greater than 80%.
Organizational Affiliation: 
Johnson & Johnson Pharmaceutical Research & Development, Welsh & McKean Roads, Spring House, PA 19477, USA.